Considerations for the Next Clinical Trial Evaluating the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma

Trials SWOG 8949 and EORTC 30947 had the same eligibility criteria and established the role of cytoreductive nephrectomy for metastatic renal cell carcinoma. The more recently published CARMENA trial calls into question the need for cytoreductive nephrectomy. A systematic comparison of CARMENA and S...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur Urol Focus
Päätekijät: Kim, Hyung L., Mayerson, Eddie, Lara, Primo N., Messing, Edward, Tangen, Cathy, Shuch, Brian M., Vaishampayan, Ulka
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6858992/
https://ncbi.nlm.nih.gov/pubmed/31103605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.euf.2019.05.006
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia